Company profile
PsyBio Therapeutics Corp
OTC: PSYBF · Healthcare · Medical - Pharmaceuticals
#1 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 30
v0.1 · 5/100 weight · pillars only
↑ workforce scale, listing tenure · ↓ Piotroski F, market scale
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
—
Employees
118
as of 2026-07-12
Market cap
$1.3k
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is PsyBio Therapeutics Corp’s financial profile?
PsyBio Therapeutics Corp has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Assure Holdings Corp.——9 Meters Biopharma, Inc.——MSP Recovery, Inc.——FusionPharm, Inc.——HLK Biotech Holding Group, Inc.——Sunset Island Group, Inc.——Neighbors
Denver →Key facts
CEOEvan Levine
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersDenver, CO
ExchangeOTC: PSYBF
Employees118
IPO date2021-04-23
Latest filings
No filings loaded.
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.